THE DEAL, AT A GLANCE
From the announcementIMU
01What it doesIMU is a Digital Health company focused on decode the immune system at scale.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02Who is involvedBacked by IQ Capital, Molten Ventures, the latest round will support IMU’s operational expansion, development of clinical platformFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03What happenedIMU raised $53M Series A, announced 2026-06-02From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗04Why it mattersIMU’s $53M Series A positions the company to expand operations and build clinical platform infrastructure around immune-system decoding.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
IMU · Financing Record
Explore source-linked visual explanations for IMU. Unsupported claims are withheld while source review continues.
Record 5160 · Recorded date: 2026-06-02
Explore company records →